Literature DB >> 21239756

Assessment of subclinical vascular disease associated with ankylosing spondylitis.

Nóra Bodnár1, György Kerekes, Ildikó Seres, György Paragh, János Kappelmayer, Zsuzsanna Gyurcsik Némethné, Gyula Szegedi, Yehuda Shoenfeld, Sándor Sipka, Pál Soltész, Zoltán Szekanecz, Sándor Szántó.   

Abstract

OBJECTIVE: Studies indicate that ankylosing spondylitis (AS), as well as rheumatoid arthritis, may be associated with accelerated atherosclerosis and vascular disease. We assessed endothelial dysfunction, carotid atherosclerosis, and aortic stiffness in AS in context with clinical and laboratory measurements.
METHODS: Forty-three patients with AS and 40 matched healthy controls were studied. We assessed common carotid intima-media thickness (ccIMT), flow-mediated vasodilation (FMD), and pulse-wave velocity (PWV) in association with age, disease duration, smoking habits, body mass index, patient's assessment of pain and disease activity, Bath AS Disease Activity Index, Bath AS Functional Index (BASFI), metric measurements, erythrocyte sedimentation rate, C-reactive protein, and HLA-B27 status.
RESULTS: We found impaired FMD (6.85 ± 2.98% vs 8.30 ± 3.96%; p = 0.005), increased ccIMT (0.65 ± 0.15 vs 0.54 ± 0.15 mm; p = 0.01), and higher PWV (8.64 ± 2.44 vs 8.00 ± 1.46 m/s; p = 0.03) in patients with AS compared to controls, respectively. We also found that ccIMT negatively correlated with FMD (r = -0.563; p = 0.0001) and positively correlated with PWV (r = 0.374; p = 0.018). Both ccIMT and PWV correlated with disease duration (r = 0.559; p = 0.013 and r = 0.520; p = 0.022, respectively), BASFI (r = 0.691; p = 0.003 and r = 0.654; p = 0.006), decreased lumbar spine mobility (r = -0.656; p = 0.006 and r = -0.604; p = 0.013), chest expansion (r = -0.502; p = 0.047 and r = -0.613; p = 0.012), and increased wall-occiput distance (r = 0.509; p = 0.044 and r = 0.614; p = 0.011).
CONCLUSION: In this well characterized AS population, impaired FMD and increased ccIMT and PWV indicate abnormal endothelial function and increased atherosclerosis and aortic stiffness, respectively. The value of noninvasive diagnostic tools needs to be further characterized.

Entities:  

Mesh:

Year:  2011        PMID: 21239756     DOI: 10.3899/jrheum.100668

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  35 in total

1.  Association between arterial stiffness, disease activity and functional impairment in ankylosing spondylitis patients: a cross-sectional study.

Authors:  Claudiu Avram; Răzvan Gabriel Drăgoi; Horațiu Popoviciu; Mihai Drăgoi; Adina Avram; Elena Amaricăi
Journal:  Clin Rheumatol       Date:  2016-05-12       Impact factor: 2.980

2.  Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis.

Authors:  Edit Végh; György Kerekes; Anita Pusztai; Attila Hamar; Szilvia Szamosi; Andrea Váncsa; Levente Bodoki; Lilla Pogácsás; Fruzsina Balázs; Katalin Hodosi; Andrea Domján; Sándor Szántó; Zoltán Nagy; Zoltán Szekanecz; Gabriella Szűcs
Journal:  Rheumatol Int       Date:  2019-12-17       Impact factor: 2.631

Review 3.  Validated methods for assessment of subclinical atherosclerosis in rheumatology.

Authors:  György Kerekes; Pál Soltész; Michael T Nurmohamed; Miguel A Gonzalez-Gay; Maurizio Turiel; Edit Végh; Yehuda Shoenfeld; Iain McInnes; Zoltán Szekanecz
Journal:  Nat Rev Rheumatol       Date:  2012-02-21       Impact factor: 20.543

Review 4.  Managing cardiovascular risk in patients with inflammatory arthritis: practical considerations.

Authors:  Anne Tournadre; Sylvain Mathieu; Martin Soubrier
Journal:  Ther Adv Musculoskelet Dis       Date:  2016-09-05       Impact factor: 5.346

5.  Assessment of aortic stiffness in patients with ankylosing spondylitis using cardiovascular magnetic resonance.

Authors:  P Stefan Biesbroek; Sjoerd C Heslinga; Peter M van de Ven; Mike J L Peters; Raquel P Amier; Thelma C Konings; Christopher D Maroules; Colby Ayers; Parag H Joshi; Irene E van der Horst-Bruinsma; Vokko P van Halm; Albert C van Rossum; Michael T Nurmohamed; Robin Nijveldt
Journal:  Clin Rheumatol       Date:  2018-05-12       Impact factor: 2.980

Review 6.  Sex and Cardiovascular Involvement in Inflammatory Joint Diseases.

Authors:  Santos Castañeda; Carlos González-Juanatey; Miguel A González-Gay
Journal:  Clin Rev Allergy Immunol       Date:  2019-06       Impact factor: 8.667

7.  Factors associated with accelerated subclinical atherosclerosis in patients with spondyloarthritis without overt cardiovascular disease.

Authors:  Alessandro Giollo; Andrea Dalbeni; Giovanni Cioffi; Federica Ognibeni; Davide Gatti; Luca Idolazzi; Giovanni Orsolini; Pietro Minuz; Maurizio Rossini; Cristiano Fava; Ombretta Viapiana
Journal:  Clin Rheumatol       Date:  2017-09-09       Impact factor: 2.980

Review 8.  Application of Non-invasive Imaging in Inflammatory Disease Conditions to Evaluate Subclinical Coronary Artery Disease.

Authors:  Harry Choi; Domingo E Uceda; Amit K Dey; Nehal N Mehta
Journal:  Curr Rheumatol Rep       Date:  2019-12-12       Impact factor: 4.592

9.  Relationship of serum osteoprotegerin with arterial stiffness, preclinical atherosclerosis, and disease activity in patients with ankylosing spondylitis.

Authors:  Münevver Serdaroğlu Beyazal; Turan Erdoğan; Aysegül Kücükali Türkyılmaz; Gül Devrimsel; Medine Cumhur Cüre; Mehmet Beyazal; Ismail Sahin
Journal:  Clin Rheumatol       Date:  2016-02-04       Impact factor: 2.980

Review 10.  Cardiovascular and cerebrovascular diseases in ankylosing spondylitis: current insights.

Authors:  Michael T Nurmohamed; Irene van der Horst-Bruinsma; Walter P Maksymowych
Journal:  Curr Rheumatol Rep       Date:  2012-10       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.